M11.112 Familial chondrocalcinosis, left shoulder

Name of the Condition

• Familial chondrocalcinosis, left shoulder

Summary

Familial chondrocalcinosis, left shoulder is a hereditary condition marked by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the left shoulder joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and left shoulder-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, left shoulder is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the left shoulder’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Shoulder trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Left shoulder pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Limited range of motion in the left shoulder.
• Joint tenderness or warmth.

Diagnosis

Diagnosis of familial chondrocalcinosis, left shoulder involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI), and sometimes analysis of joint fluid or tissue to identify CPPD crystals. Clinical evaluation focuses on symptoms and family history, while imaging may reveal characteristic crystal deposits or joint changes. Crystal identification in synovial fluid confirms the diagnosis in ambiguous cases.

Treatment Options

Treatment aims to manage pain, reduce inflammation, and preserve joint function. Options include nonsteroidal anti-inflammatory drugs (NSAIDs) for acute flares, corticosteroid injections for localized inflammation, and colchicine for recurrent episodes. Physical therapy may help maintain mobility. In severe cases, surgical intervention (e.g., joint lavage or arthroscopy) may be considered to remove crystals or repair damaged tissue.

Prognosis and Follow-Up

Prognosis varies depending on the extent of joint damage and response to treatment. Early intervention can mitigate symptoms and slow progression, but chronic cases may lead to persistent pain or functional limitations. Regular follow-up with a healthcare provider is recommended to monitor joint health, adjust treatment, and address complications.

Complications

Potential complications include chronic joint damage, reduced mobility, recurrent acute flares, and secondary osteoarthritis. In rare cases, severe inflammation may lead to joint deformity or disability if left untreated.

Lifestyle & Prevention

Lifestyle modifications may help manage symptoms, such as avoiding repetitive shoulder strain, maintaining a healthy weight to reduce joint stress, and engaging in low-impact exercises to preserve mobility. While genetic predisposition cannot be prevented, prompt treatment of acute episodes may limit long-term damage.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe left shoulder pain, swelling, or inability to move the joint, as these may indicate an acute flare. Persistent pain, stiffness, or worsening symptoms despite home care also warrant evaluation to prevent complications.

Tips for Medical Coders

Document the left shoulder involvement and familial nature of the condition to support accurate coding. Ensure clinical notes specify the anatomical site (left shoulder) and confirm the hereditary aspect, as these details are critical for assigning M11.112. Avoid using this code for non-familial or bilateral cases, as specificity is required.